CASC8 and pancreatic adenocarcinoma: Additionally, we verified the clinical significance of the four sARLNRs and found that the expression levels of CASC8 and AC015660.1 were significantly higher in PAAD cell lines and tumor tissues especially in patients with advanced grades and T-stages, while Z97832.2 and PAN3-AS1 were inverse.